SynthesisCurrent pain and headache reports2026
Safety and Efficacy of Perioperative Magnesium Sulfate Injection for Postoperative Pain Management and Opioid Sparing Effects in Surgeries of the Nervous System: A Systematic Review and Meta Analysis.
Synthesis in Current pain and headache reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPostoperative pain following spinal and neurological surgeries is often severe and can hinder recovery, mobilization, and increase risk of chronic pain. While opioids are the traditional standard for pain management, associated risks and the ongoing opioid crisis necessitate alternative therapies. Magnesium sulfate, an NMDA receptor antagonist and calcium channel blocker, has shown promise in reducing postoperative pain and opioid consumption.
methodsThe present investigation utilized a systematic search for studies from PubMed, Embase, and Web of Science. Sources were eligible for inclusion in this review if published from 2010 to present, if patients received a spinal or neurological surgery regardless of patient age, country, race, and gender, and if the source was a randomized control trial, case report, or case series. Sources in non-English, without full-text access, and systematic reviews/meta-analyses were excluded, as well as studies focused on non-human subjects or studies with adjuvant therapies. Nine randomized controlled trials met our criteria. Pain scores (VAS/NRS) and opioid consumption were the primary outcomes. Meta-analysis was conducted using Cochrane Review Manager with fixed or random-effects models depending on heterogeneity.
resultsMagnesium sulfate significantly reduced pain scores at rest at multiple postoperative time points, including 0 h (MD=- 0.79; p = 0.004), 4 h (MD= -1.03, p < 0.00001), 24 h (MD= -0.78: p = 0.005), and 48 h (MD= -0.67: p = 0.0006). Opioid consumption was also significantly reduced at various intervals. No major adverse events were reported.
conclusionPerioperative magnesium sulfate infusion is a safe and effective adjunct for reducing postoperative pain and opioid use in spinal surgery patients, with potential applications in neurological procedures pending further research.
Indexed as
Identifiers
42417898What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.